OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials
Faı̈ez Zannad, Arun J. Sanyal, Javed Butler, et al.
Journal of Internal Medicine (2024) Vol. 296, Iss. 1, pp. 24-38
Open Access | Times Cited: 6
Faı̈ez Zannad, Arun J. Sanyal, Javed Butler, et al.
Journal of Internal Medicine (2024) Vol. 296, Iss. 1, pp. 24-38
Open Access | Times Cited: 6
Showing 6 citing articles:
We Need Simpler and More Integrated Guidelines in Cardio-Kidney-Metabolic Diseases
João Pedro Ferreira, Faı̈ez Zannad
JACC Heart Failure (2025)
Closed Access
João Pedro Ferreira, Faı̈ez Zannad
JACC Heart Failure (2025)
Closed Access
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
Christopher D. Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Christopher D. Byrne, Angelo Armandi, Vanessa Pellegrinelli, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Preclinical Research on Cinnamic Acid Derivatives for the Prevention of Liver Damage: Promising Therapies for Liver Diseases
Liseth Rubí Aldaba-Muruato, Brayan Escalante-Hipólito, Aldo Yoshio Alarcón-López, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1094-1094
Open Access
Liseth Rubí Aldaba-Muruato, Brayan Escalante-Hipólito, Aldo Yoshio Alarcón-López, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1094-1094
Open Access
Integrating liver endpoints in clinical trials of cardiovascular and kidney disease
Faı̈ez Zannad, Arun J. Sanyal, Javed Butler, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2423-2431
Closed Access | Times Cited: 3
Faı̈ez Zannad, Arun J. Sanyal, Javed Butler, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2423-2431
Closed Access | Times Cited: 3
Sex differences in pathogenesis and treatment of dyslipidemia in patients with type 2 diabetes and steatotic liver disease
Tatjána Ábel, Béla Benczúr, Éva Csajbókné Csobod
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Tatjána Ábel, Béla Benczúr, Éva Csajbókné Csobod
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Role of MASLD in CVD: A review of emerging treatment options
Rocco Mollace, Susanna Longo, Matteo Nardin, et al.
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111891-111891
Open Access | Times Cited: 1
Rocco Mollace, Susanna Longo, Matteo Nardin, et al.
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111891-111891
Open Access | Times Cited: 1
The Impact of Circadian Rhythms and Obesity on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Analysis of NHANES 2017-2020 Data
Xiaoxuan Tang, Fenglan Wang, Yujia Gao, et al.
(2024)
Closed Access
Xiaoxuan Tang, Fenglan Wang, Yujia Gao, et al.
(2024)
Closed Access
